131 – 140 of 244
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Benefit From Reperfusion With Primary Percutaneous Coronary Intervention Beyond 12 Hours of Symptom Duration in Patients With ST-Segment-Elevation Myocardial Infarction
- Contribution to journal › Article
-
Mark
External Validation of the DAPT Score in a Nationwide Population
- Contribution to journal › Article
-
Mark
High time to omit oxygen therapy in ST elevation myocardial infarction
- Contribution to journal › Debate/Note/Editorial
-
Mark
Longitudinal left ventricular function is globally depressed within a week of STEMI
- Contribution to journal › Article
-
Mark
Impact of diagnostic ECG-to-wire delay in STEMI patients treated with primary PCI : A DANAMI-3 substudy
- Contribution to journal › Article
-
Mark
No benefit of ticagrelor pretreatment compared with treatment during percutaneous coronary intervention in patients with ST-segment⇓elevation myocardial infarction undergoing primary percutaneous coronary intervention
- Contribution to journal › Article
-
Mark
Long-Term Effects of Oxygen Therapy on Death or Hospitalization for Heart Failure in Patients With Suspected Acute Myocardial Infarction
- Contribution to journal › Article
-
Mark
Women's Health in the Lund Area (WHILA) study. Health problems and acute myocardial infarction in women – A 17-year follow-up study
- Contribution to journal › Article
- 2017
-
Mark
Cangrelor in combination with ticagrelor provides consistent and potent P2Y12-inhibition during and after primary percutaneous coronary intervention in real-world patients with ST-segment-elevation myocardial infarction
- Contribution to journal › Article
-
Mark
On the influence of heart rate and coupling interval prematurity on heart rate turbulence
- Contribution to journal › Article
